The School of Law marked its 60th anniversary with a celebratory event held at the heart of Queen Mary’s Mile End campus.
The technology opens the door to developing a wide range of new treatments for autoimmune and inflammatory diseases ...
Scientists from the Department of Geography and Environmental Science at Queen Mary University of London have developed a ...
Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed ...
Yesterday (Thursday 23 October), Queen Mary University of London recognised and celebrated the winners of the 2024/2025 ...
Announced at the House of Lords, findings from the paper in The Lancet: Healthy Longevity demonstrate that the intervention, ...
Rapalink-1, the new drug studied by the team, is a next-generation TOR inhibitor currently under investigation for cancer ...
The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify ...
Queen Mary University of London and Barking and Dagenham Council have launched a major new partnership to tackle local health ...
Queen Mary University of London has partnered with the MassChallenge startup accelerator to offer a new route to impact for ...
Titled ‘Equitable Partnerships for Civic Engagement: A Toolkit for Civic, Community and University Partners ’, the resource ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback